These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 34532348)
1. Coronary Artery Disease: Optimal Lipoprotein(a) for Survival-Lower Is Better? A Large Cohort With 43,647 Patients. Liu J; Liu L; Wang B; Chen S; Liu B; Liang J; Huang H; Li Q; Lun Z; Ying M; Chen G; Huang Z; Xu D; Yan X; Zhu T; Tadesse GA; Tan N; Chen J; Liu Y Front Cardiovasc Med; 2021; 8():670859. PubMed ID: 34532348 [No Abstract] [Full Text] [Related]
2. Triglyceride to high-density lipoprotein cholesterol ratio as a predictor of long-term mortality in patients with coronary artery disease after undergoing percutaneous coronary intervention: a retrospective cohort study. Dai XY; Zheng YY; Tang JN; Yang XM; Guo QQ; Zhang JC; Cheng MD; Song FH; Liu ZY; Wang K; Jiang LZ; Fan L; Yue XT; Bai Y; Zhang ZL; Zheng RJ; Zhang JY Lipids Health Dis; 2019 Dec; 18(1):210. PubMed ID: 31801554 [TBL] [Abstract][Full Text] [Related]
3. Association of dysglycemia and all-cause mortality across the spectrum of coronary artery disease. Yang SW; Zhou YJ; Tian XF; Pan GZ; Liu YY; Zhang J; Guo ZF; Chen SY; Gao ST; Du J; Jia DA; Fang Z; Hu B; Han HY; Gao F; Hu DY; Xu YY; Mayo Clin Proc; 2013 Sep; 88(9):930-41. PubMed ID: 24001485 [TBL] [Abstract][Full Text] [Related]
4. Effect of Lipoprotein (a) Levels on Long-term Cardiovascular Outcomes in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries. Gao S; Ma W; Huang S; Lin X; Yu M Am J Cardiol; 2021 Aug; 152():34-42. PubMed ID: 34130824 [TBL] [Abstract][Full Text] [Related]
5. White Blood Cell Counts to High-Density Lipoprotein Cholesterol Ratio, as a Novel Predictor of Long-Term Adverse Outcomes in Patients After Percutaneous Coronary Intervention: A Retrospective Cohort Study. Wu TT; Zheng YY; Xiu WJ; Wang WR; Xun YL; Ma YY; Kadir P; Pan Y; Ma YT; Xie X Front Cardiovasc Med; 2021; 8():616896. PubMed ID: 34307487 [No Abstract] [Full Text] [Related]
6. The U-Shaped Relationship Between Serum Uric Acid and Long-Term All-Cause Mortality in Coronary Artery Disease Patients: A Cohort Study of 33,034 Patients. Zheng Y; Ou J; Huang D; Zhou Z; Dong X; Chen J; Liang D; Liu J; Liu Y; Chen J; Huang X; Tan N Front Cardiovasc Med; 2022; 9():858889. PubMed ID: 35811724 [TBL] [Abstract][Full Text] [Related]
7. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. Muhlestein JB; Lappé DL; Lima JA; Rosen BD; May HT; Knight S; Bluemke DA; Towner SR; Le V; Bair TL; Vavere AL; Anderson JL JAMA; 2014 Dec; 312(21):2234-43. PubMed ID: 25402757 [TBL] [Abstract][Full Text] [Related]
8. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention. Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869 [TBL] [Abstract][Full Text] [Related]
9. Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients. Yao Y; Liu J; Wang B; Zhou Z; Lu X; Huang Z; Deng J; Yang Y; Tan N; Chen S; Chen J; Liu Y Front Cardiovasc Med; 2021; 8():817442. PubMed ID: 35097030 [No Abstract] [Full Text] [Related]
10. Predicting Cardiovascular Outcomes by Baseline Lipoprotein(a) Concentrations: A Large Cohort and Long-Term Follow-up Study on Real-World Patients Receiving Percutaneous Coronary Intervention. Liu HH; Cao YX; Jin JL; Zhang HW; Hua Q; Li YF; Guo YL; Zhu CG; Wu NQ; Xu RX; Chen XH; Li JJ J Am Heart Assoc; 2020 Feb; 9(3):e014581. PubMed ID: 32013705 [TBL] [Abstract][Full Text] [Related]
11. Effect of Cerebrovascular and/or Peripheral Artery Disease With or Without Attainment of Lipid Goals on Long-Term Outcomes in Patients With Coronary Artery Disease. Volis I; Saliba W; Jaffe R; Eitan A; Zafrir B Am J Cardiol; 2020 Aug; 128():28-34. PubMed ID: 32650921 [TBL] [Abstract][Full Text] [Related]
12. Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients. Sultani R; Tong DC; Peverelle M; Lee YS; Baradi A; Wilson AM Heart Lung Circ; 2020 Mar; 29(3):414-421. PubMed ID: 31014557 [TBL] [Abstract][Full Text] [Related]
13. Association of lipoprotein(a) with long-term mortality following coronary angiography or percutaneous coronary intervention. Feng Z; Li HL; Bei WJ; Guo XS; Wang K; Yi SX; Luo DM; Li XD; Chen SQ; Ran P; Chen PY; Islam SMS; Chen JY; Liu Y; Zhou YL Clin Cardiol; 2017 Sep; 40(9):674-678. PubMed ID: 28444976 [TBL] [Abstract][Full Text] [Related]
14. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease. Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575 [TBL] [Abstract][Full Text] [Related]
15. The association between prothrombin time-international normalized ratio and long-term mortality in patients with coronary artery disease: a large cohort retrospective study with 44,662 patients. Liu L; Ying M; Chen S; Li Q; Chen G; Li H; Mai Z; He Y; Wang B; Xu D; Huang Z; Yan X; Tan N; Chen Z; Liu J; Liu Y BMC Cardiovasc Disord; 2022 Jun; 22(1):297. PubMed ID: 35768760 [TBL] [Abstract][Full Text] [Related]
16. Baseline plasma lipid levels in patients with acute coronary syndrome: Association with 20-year mortality. The ABC-5a* Study on Heart Disease. Berton G; Cordiano R; Mahmoud HT; Palmieri R; Cavuto F; Pasquinucci M Int J Clin Pract; 2020 Jun; 74(6):e13492. PubMed ID: 32083393 [TBL] [Abstract][Full Text] [Related]